Vanda Pharmaceuticals | Betriebsergebnis





Betriebsergebnis Veränderung Datum
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Anika Therapeutics USD -4.28M 32.1M 2025-03
Arrowhead Research USD 40.81M 3.3M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Enanta Pharmaceuticals USD -23.54M 98.15M 2024-12
Esperion Therapeutics USD -16.03M 18.6M 2024-09
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Heron Therapeutics USD -5.66M 782K 2024-09
Insmed USD -249.71M 11.64M 2025-12
J&J USD 5.59B 1.81B 2025-12
Lexicon Pharmaceuticals USD -55.35M 10.02M 2024-06
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
Merck USD 6.24B 318M 2025-12
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Moderna USD -857M 597M 2025-12
Novartis USD 4.58B 879M 2025-09
Pfizer USD 4.65B 3.99B 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD 22.08M 24.26M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 1.7B 2.17B 2025-12
Takeda JPY 168.82B 479.89B 2025-12
Teva Pharmaceutical Industries USD 487M 581M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12
Veracyte USD 24.63M 1.52M 2025-12


Vanda Pharmaceuticals Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.